Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Brian S. Barnett

28 indexed publications match this author name.

ORCID: 0000-0002-8963-5701
OpenAlex: https://openalex.org/A5018028836

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Addiction 11 Depression 9 Safety 9 Observational Study 9 Clinical Trial 7 Mechanism of Action 7 Receptor Pharmacology 5 Review Article 5 PTSD 3 Healthcare Workers 3 Case Report 3 General 3

Journals

Journal of psychoactive drugs 5 medRxiv 3 bioRxiv 2 Psychedelic medicine (New Rochelle, N.Y.) 2 Journal of Affective Disorders 1 Drugs Education Prevention and Policy 1 CNS drugs 1 Psychiatry research 1

Publication history

Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-06-01 Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety RecommendationsmedRxiv · 2026-04-30 “You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practiceDrugs Education Prevention and Policy · 2026-03-22 Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.CNS drugs · 2026-03-01 The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.Psychiatry research · 2025-06-01 Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation.Journal of psychoactive drugs · 2025-03-14 Psychedelic-assisted therapy: An overview for the internist.Cleveland Clinic journal of medicine · 2025-03-03 Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts.Journal of psychoactive drugs · 2025-03-01 Funding Success of United States Federal Grant Applications Proposing to Study Therapeutic Applications of Psychedelics: A Survey StudyPsychoactives · 2025-02-05 Practical considerations in the establishment of psychedelic research programs.Psychopharmacology · 2025-01-01 Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.Journal of psychoactive drugs · 2025-01-01 Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathwaysbioRxiv · 2024-12-17 A survey investigating United States federal grant submissions proposing to investigate therapeutic applications of psychedelicsmedRxiv · 2024-10-13 American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey.Psychedelic medicine (New Rochelle, N.Y.) · 2024-03-01 Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.Psychedelic medicine (New Rochelle, N.Y.) · 2023-09-01 Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom useDrug Science Policy and Law · 2023-01-01 Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies.Journal of psychoactive drugs · 2023-01-01 Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.Frontiers in psychiatry · 2023-01-01 Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD.Journal of psychoactive drugs · 2023-01-01 Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.Journal of psychopharmacology (Oxford, England) · 2022-10-01 Psychedelics in the Treatment of Substance Use DisordersPsychiatric Annals · 2022-09-01 United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.The International journal on drug policy · 2022-01-01 Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical StudiesmedRxiv · 2021-11-24 Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.Journal of the Academy of Consultation-Liaison Psychiatry · 2021-01-01 Decreased Directed Functional Connectivity in the Psychedelic StatebioRxiv · 2019-07-16 Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatographyScience & Justice · 2006-04-01 The Determination of Psilocin and Psilocybin in Hallucinogenic Mushrooms by HPLC Utilizing a Dual Reagent Acidic Potassium Permanganate and Tris(2,2′-bipyridyl)ruthenium(II) Chemiluminescence Detection SystemJournal of Forensic Sciences · 2006-01-01 Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection respectivelyTalanta · 2005-08-15

Author directory